Zeria Pharmaceutical Co Ltd
Company Profile
Business description
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment. Geographically, the company operates its sale in Japan, Europe and others further expanding in Asian regions.
Contact
10-11, Nihonbashi Kobunacho
Chuo-ku
Tokyo103-8351
JPNT: +81 336632351
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,891
Stocks News & Analysis
stocks
ASX utility share downgraded as electricity prices fall
stocks
Chart of the Week: AI market leader is now surprisingly cheap
stocks
Weekly earnings wrap: Rio Tinto leads the way
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,457.00 | 47.10 | 0.50% |
| CAC 40 | 8,669.30 | 0.00 | 0.00% |
| DAX 40 | 26,126.30 | 76.05 | -0.29% |
| Dow JONES (US) | 54,349.12 | 263.24 | 0.49% |
| FTSE 100 | 10,888.30 | 8.92 | 0.08% |
| HKSE | 25,593.28 | 322.54 | -1.24% |
| NASDAQ | 26,363.44 | 221.55 | -0.83% |
| Nikkei 225 | 65,027.59 | 1,272.85 | -1.92% |
| NZX 50 Index | 13,995.74 | 1.44 | -0.01% |
| S&P 500 | 7,723.55 | 12.97 | -0.17% |
| S&P/ASX 200 | 9,280.60 | 50.80 | 0.55% |
| SSE Composite Index | 3,866.55 | 11.88 | -0.31% |